Interstitial Lung Disease Research Cluster (#1): Key biomarkers include systemic sclerosis, rheumatoid arthritis, KL-6, acute exacerbation, risk, diagnosis, and nintedanib. The gene discussed is MUC1; the disease is lung disorder.